Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Catherine Toong, Stephen Adelstein & Tri Giang Phan. (2011) Clearing the complexity: immune complexes and their treatment in lupus nephritis. International Journal of Nephrology and Renovascular Disease 4, pages 17-28.
Read now
Read now
Articles from other publishers (21)
Kenei Sada, Noriaki Kurita, Hisashi Noma, Taizo Matsuki, Holly Quasny, Roger A Levy, Angela R Jones-Leone, Kerry Gairy & Nobuyuki Yajima. (2022) MOONLIGHT study: the design of a comparative study of the effectiveness of belimumab in patients with a history of lupus nephritis from the post-Marketed effectiveness of belimumab cOhOrt and JapaN Lupus NatIonwide reGistry (LUNA) coHorT. Lupus Science & Medicine 9:1, pages e000746.
Crossref
Crossref
Lorenza Maria Argolini, Giulia Frontini, Elena Elefante, Francesca Saccon, Valentina Binda, Chiara Tani, Isabella Scotti, Linda Carli, Mariele Gatto, Ciro Esposito, Maria Gerosa, Roberto Caporali, Andrea Doria, Piergiorgio Messa, Marta Mosca & Gabriella Moroni. (2020) Multicentric study comparing cyclosporine, mycophenolate mofetil and azathioprine in the maintenance therapy of lupus nephritis: 8 years follow up. Journal of Nephrology 34:2, pages 389-398.
Crossref
Crossref
Daniel Xibillé-Friedmann, Marcela Pérez-Rodríguez, Sandra Carrillo-Vázquez, Everardo Álvarez-Hernández, Francisco Javier Aceves, Mario C. Ocampo-Torres, Conrado García-García, José Luis García-Figueroa, Javier Merayo-Chalico, Ana Barrera-Vargas, Margarita Portela-Hernández, Sandra Sicsik, Lilia Andrade-Ortega, Víctor Manuel Rosales-Don Pablo, Aline Martínez, Pilar Prieto-Seyffert, Mario Pérez-Cristóbal, Miguel Ángel Saavedra, Zully Castro-Colín, Azucena Ramos, Gabriela Huerta-Sil, María Fernanda Hernández-Cabrera, Luis Javier Jara, Leonardo Limón-Camacho, Lizbet Tinajero-Nieto & Leonor A. Barile-Fabris. (2019) Clinical Practice Guidelines for the Treatment of Systemic Lupus Erythematosus by the Mexican College of Rheumatology. Reumatología Clínica (English Edition) 15:1, pages 3-20.
Crossref
Crossref
Daniel Xibillé-Friedmann, Marcela Pérez-Rodríguez, Sandra Carrillo-Vázquez, Everardo Álvarez-Hernández, Francisco Javier Aceves, Mario C. Ocampo-Torres, Conrado García-García, José Luis García-Figueroa, Javier Merayo-Chalico, Ana Barrera-Vargas, Margarita Portela-Hernández, Sandra Sicsik, Lilia Andrade-Ortega, Víctor Manuel Rosales-Don Pablo, Aline Martínez, Pilar Prieto-Seyffert, Mario Pérez-Cristóbal, Miguel Ángel Saavedra, Zully Castro-Colín, Azucena Ramos, Gabriela Huerta-Sil, María Fernanda Hernández-Cabrera, Luis Javier Jara, Leonardo Limón-Camacho, Lizbet Tinajero-Nieto & Leonor A. Barile-Fabris. (2019) Guía de práctica clínica para el manejo del lupus eritematoso sistémico propuesta por el Colegio Mexicano de Reumatología. Reumatología Clínica 15:1, pages 3-20.
Crossref
Crossref
S. Tavakolpour, M. Darvishi & M. Ghasemiadl. (2018) Pharmacogenetics: A strategy for personalized medicine for autoimmune diseases. Clinical Genetics 93:3, pages 481-497.
Crossref
Crossref
Y. H. Lee & G. G. Song. (2016) Comparative efficacy and safety of tacrolimus, mycophenolate mofetil, azathioprine, and cyclophosphamide as maintenance therapy for lupus nephritisVergleich der Wirksamkeit und Sicherheit von Tacrolimus, Mycophenolat-Mofetil, Azathioprin und Cyclophosphamid als Erhaltungstherapie bei Lupusnephritis. Zeitschrift für Rheumatologie 76:10, pages 904-912.
Crossref
Crossref
Zahra Rezaieyazdi, Tahmine Tavakoli, Mohammad Khajehdaluee & Shahram Honarmand. (2014) Efficacy of long-term maintenance therapy with mycophenolate mofetil in lupus nephritis. SpringerPlus 3:1.
Crossref
Crossref
A. Mohara, R. Perez Velasco, N. Praditsitthikorn, Y. Avihingsanon & Y. Teerawattananon. (2013) A cost-utility analysis of alternative drug regimens for newly diagnosed severe lupus nephritis patients in Thailand. Rheumatology 53:1, pages 138-144.
Crossref
Crossref
Li Feng, Jin Deng, Dong-Mei Huo, Qiao-Yuan Wu & Yun-Hua Liao. (2013)
Mycophenolate mofetil
versus
azathioprine as maintenance therapy for lupus nephritis: A meta-analysis
. Nephrology 18:2, pages 104-110.
Crossref
Crossref
Tomoo Kise, Masatsugu Uehara, Shigeru Fukuyama & Hiroshi Yoshimura. (2013) Mycophenolate mofetil in severe juvenile-onset lupus nephritis for five years. Nihon Shoni Jinzobyo Gakkai Zasshi 26:1, pages 1-6.
Crossref
Crossref
F. Rivera, M.L. Illescas, E. López-Rubio, J. Fulladosa, R. Poveda, J. Baltar, G. Fernández-Juárez, J. Ballarín, A. Oliet, A. Vigil, J. Lucas, M. Sierra, M.A. Frutos, P. García-Frías, C. Ramos, E. Mérida, M. Praga & A. Segarra. (2013) Mycophenolate as Maintenance Therapy for Lupus Nephritis with Impaired Renal Function. American Journal of Nephrology 37:6, pages 509-517.
Crossref
Crossref
G. Ruiz-Irastorza, G. Espinosa, M.A. Frutos, J. Jiménez Alonso, M. Praga, L. Pallarés, F. Rivera, Á. Robles Marhuenda, A. Segarra & C. Quereda. (2012) Diagnóstico y tratamiento de la nefritis lúpica. Revista Clínica Española 212:3, pages 147.e1-147.e30.
Crossref
Crossref
Mary Anne Dooley, David Jayne, Ellen M. Ginzler, David Isenberg, Nancy J. Olsen, David Wofsy, Frank Eitner, Gerald B. Appel, Gabriel Contreras, Laura Lisk & Neil Solomons. (2011) Mycophenolate versus Azathioprine as Maintenance Therapy for Lupus Nephritis. New England Journal of Medicine 365:20, pages 1886-1895.
Crossref
Crossref
Pietro A.A. Canetta & Gerald B. Appel. (2011) New and emerging treatments for lupus nephritis. Dialysis & Transplantation 40:2, pages 67-71.
Crossref
Crossref
ZAHI TOUMA, DAFNA D. GLADMAN, MURRAY B. UROWITZ, JOSEPH BEYENE, ELIZABETH M. ULERYK & PRAKESH S. SHAH. (2011) Mycophenolate Mofetil for Induction Treatment of Lupus Nephritis: A Systematic Review and Metaanalysis. The Journal of Rheumatology 38:1, pages 69-78.
Crossref
Crossref
George Bertsias, Prodromos Sidiropoulos & Dimitrios T. Boumpas. 2011. Rheumatology. Rheumatology
1317
1334.e3
.
Andrew S. Bomback & Gerald B. Appel. (2010) Updates on the Treatment of Lupus Nephritis. Journal of the American Society of Nephrology 21:12, pages 2028-2035.
Crossref
Crossref
Katerina Laskari, Clio P Mavragani, Athanasios G Tzioufas & Haralampos M Moutsopoulos. (2010) Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study. Arthritis Research & Therapy 12:6.
Crossref
Crossref
Stephen D Marks & Kjell Tullus. (2010) Modern therapeutic strategies for paediatric systemic lupus erythematosus and lupus nephritis. Acta Paediatrica 99:7, pages 967-974.
Crossref
Crossref
YH LeeJ-H. Woo, SJ Choi, JD Ji & GG Song. (2010) Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis. Lupus 19:6, pages 703-710.
Crossref
Crossref
Rachel B Jones, Michael Walsh & Kenneth GC Smith. (2009) What is the value of mycophenolate mofetil as induction and maintenance therapy in lupus nephritis?. Current Opinion in Rheumatology 21:3, pages 256-261.
Crossref
Crossref